150 related articles for article (PubMed ID: 1520840)
1. Optimization of the chronotherapeutic index in the experimental animal laboratory.
Halberg E; Cornélissen G; Halberg F
In Vivo; 1992; 6(4):371-85. PubMed ID: 1520840
[TBL] [Abstract][Full Text] [Related]
2. [Chronobiology and cancer].
Lévi F
Pathol Biol (Paris); 1987 Jun; 35(6):960-8. PubMed ID: 3306577
[TBL] [Abstract][Full Text] [Related]
3. [Chronopharmacology and chronotherapy of cancers].
Lévi F
Pathol Biol (Paris); 1996 Sep; 44(7):631-44. PubMed ID: 8977920
[TBL] [Abstract][Full Text] [Related]
4. Cancer chronotherapy: a drug delivery challenge.
Hrushesky WJ
Prog Clin Biol Res; 1990; 341A():1-10. PubMed ID: 2145583
[TBL] [Abstract][Full Text] [Related]
5. Chronotherapeutics: the relevance of timing in cancer therapy.
Lévi F
Cancer Causes Control; 2006 May; 17(4):611-21. PubMed ID: 16596317
[TBL] [Abstract][Full Text] [Related]
6. Cancer chronotherapy: is there a right time in the day to treat?
Hrushesky WJ
J Infus Chemother; 1995; 5(1):38-43. PubMed ID: 7634176
[TBL] [Abstract][Full Text] [Related]
7. [The circadian-timing system: a determinant of drug activity and a target of anticancer treatments].
Lévi F
Ann Pharm Fr; 2008 Jun; 66(3):175-84. PubMed ID: 18706346
[TBL] [Abstract][Full Text] [Related]
8. Chronotherapy and the molecular clock: Clinical implications in oncology.
Innominato PF; Lévi FA; Bjarnason GA
Adv Drug Deliv Rev; 2010 Jul; 62(9-10):979-1001. PubMed ID: 20600409
[TBL] [Abstract][Full Text] [Related]
9. When to treat.
Halberg F
Indian J Cancer; 1975 Mar; 12(1):1-20. PubMed ID: 1235777
[No Abstract] [Full Text] [Related]
10. Circadian cancer pharmacodynamics.
Hrushesky WJ
Ann Ist Super Sanita; 1993; 29(4):705-10. PubMed ID: 7985931
[TBL] [Abstract][Full Text] [Related]
11. From experimental units to unique experiments: chronobiologic pilots complement large trials.
Halberg F; Cornélissen G; Bingham C; Fujii S; Halberg E
In Vivo; 1992; 6(4):403-27. PubMed ID: 1520842
[TBL] [Abstract][Full Text] [Related]
12. Chronotherapy of growth factors.
Wood PA
J Infus Chemother; 1995; 5(1):20-3. PubMed ID: 7634172
[TBL] [Abstract][Full Text] [Related]
13. Cancer chronotherapy: principles, applications, and perspectives.
Mormont MC; Levi F
Cancer; 2003 Jan; 97(1):155-69. PubMed ID: 12491517
[TBL] [Abstract][Full Text] [Related]
14. Circadian timing in cancer treatments.
Lévi F; Okyar A; Dulong S; Innominato PF; Clairambault J
Annu Rev Pharmacol Toxicol; 2010; 50():377-421. PubMed ID: 20055686
[TBL] [Abstract][Full Text] [Related]
15. Marker rhythms for cancer chronotherapy. From laboratory animals to human beings.
Focan C
In Vivo; 1995; 9(4):283-98. PubMed ID: 8555427
[TBL] [Abstract][Full Text] [Related]
16. Chronobiology in hematology and immunology.
Haus E; Lakatua DJ; Swoyer J; Sackett-Lundeen L
Am J Anat; 1983 Dec; 168(4):467-517. PubMed ID: 6364772
[TBL] [Abstract][Full Text] [Related]
17. A novel approach for improving the efficacy of experimental cancer chemotherapy using combinations of anticancer drugs and L-histidinol.
Warrington RC
Anticancer Res; 1986; 6(3 Pt B):451-64. PubMed ID: 3090929
[TBL] [Abstract][Full Text] [Related]
18. Chronotherapy of cancer: biological basis and clinical application.
Lévi F
Pathol Biol (Paris); 1994 Apr; 42(4):338-41. PubMed ID: 7808787
[TBL] [Abstract][Full Text] [Related]
19. Biological perspectives on circadian cancer therapy.
Wood PA; Hrushesky WJ
J Infus Chemother; 1995; 5(4):182-90. PubMed ID: 8934723
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, safety, and efficacy of a liposome encapsulated thymidylate synthase inhibitor, OSI-7904L [(S)-2-[5-[(1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl]-glutaric acid] in mice.
Desjardins J; Emerson DL; Colagiovanni DB; Abbott E; Brown EN; Drolet DW
J Pharmacol Exp Ther; 2004 Jun; 309(3):894-902. PubMed ID: 14982966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
